Potential for Combination Therapy Another exciting avenue for the use of GLP-1 receptor agonists in addiction treatment is their potential use in combination therapies
Beyond the absolute contraindications, several situations call for heightened caution in the class framing and are firmly a clinicians domain: a history of pancreatitis or symptomatic gallstones, significant gastrointestinal motility disorders (such as gastroparesis, which slowed gastric emptying can worsen), diabetic retinopathy that is not stabilized, severe renal impairment where dehydration from GI side effects raises risk, and any concurrent use of insulin or a sulfonylurea, where the additive glucose-lowering can produce hypoglycemia
Their ability to promote weight loss and glycemic control is comparable, Dr
Google Scholar Zong H, Sen S, Zhang G
Half-life ~23 hours plasma
The membranes were incubated with primary antibodies at 4C overnight